SG/CALL/WALGREENS BOOTS ALLIANCE/35/0.1/20.09.24 Stock

Warrant

DE000SQ80FB2

Market Closed - Deutsche Boerse AG 03:48:07 2024-05-30 pm EDT
0.002 EUR +100.00% Intraday chart for SG/CALL/WALGREENS BOOTS ALLIANCE/35/0.1/20.09.24
Current month+100.00%
1 month+100.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-30 0.002 +100.00%
24-05-29 0.001 0.00%
24-05-28 0.001 0.00%
24-05-27 0.001 0.00%
24-05-24 0.001 0.00%

Delayed Quote Deutsche Boerse AG

Last update May 30, 2024 at 03:48 pm EDT

More quotes

Static data

Product typePlain-Vanilla-Warrants
Buy / SellCALL
Underlying WALGREENS BOOTS ALLIANCE, INC.
IssuerLogo Issuer Société Générale Société Générale
WKN SQ80FB
ISINDE000SQ80FB2
Date issued 2023-02-13
Strike 35 $
Maturity 2024-09-20 (113 Days)
Parity 10 : 1
Emission price 0.51
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 0.58
Lowest since issue 0.001

Company Profile

Walgreens Boots Alliance, Inc. specializes in the distribution of pharmaceutical products. Net sales break down by activity as follows: - retail distribution (87.2%): selling prescription drugs, OTC medicines, beauty and cosmetic products, etc. in the United States (90.9% of net sales) and internationally (9.1%). At the end of August 2023, the activity is carried out through 13,532 outlets (of which 8,706 located in the United States, Puerto Rico and the US Virgin Islands), and through the Internet; - wholesale distribution (8.1%). The remaining sales (4.7%) are from the healthcare Net sales break down geographically as follows: the United States (84%), Germany (8.1%), the United Kingdom (6.5%) and other (1.4%).
Sector
-
More about the company

Ratings for Walgreens Boots Alliance, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
B-
More Ratings

Consensus: Walgreens Boots Alliance, Inc.

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
15.39 USD
Average target price
22.77 USD
Spread / Average Target
+47.96%
Consensus